Market Capitalization (Millions $) |
56 |
Shares
Outstanding (Millions) |
17 |
Employees |
- |
Revenues (TTM) (Millions $) |
- |
Net Income (TTM) (Millions $) |
-4 |
Cash Flow (TTM) (Millions $) |
48 |
Capital Exp. (TTM) (Millions $) |
1 |
Renovacor Inc
Renovacor Inc is a biotechnology company that focuses on developing gene therapies for cardiac conditions. Their aim is to develop innovative treatments for patients with debilitating heart diseases. Renovacor is dedicated to improving the quality of life of individuals affected by genetic cardiovascular disorders by utilizing gene therapy techniques to correct the underlying genetic mutations causing these conditions. They strive to bring their gene therapies to the market to address the unmet medical needs of patients with cardiovascular diseases.
Company Address: 201 Broadway Cambridge 2139 MA
Company Phone Number: 424-2650 Stock Exchange / Ticker: NYSEAMER RCOR
|